newsfilter
← Latest News
Business Wire·

AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

  • AN2 Therapeutics announced that Co-Founder Eric Easom will present at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 12:50 PM ET.
  • Management members will be available for one-on-one meetings following the presentation.
  • A webcast of the event will be accessible via the Investors section of the AN2 Therapeutics website, with an archived replay available for at least 30 days.
  • AN2 Therapeutics is a clinical-stage biopharmaceutical company utilizing a boron chemistry platform to develop small-molecule therapeutics for hematologic diseases, infectious diseases, & oncology.
  • The company expects three Phase 2 studies to be active in 2026, alongside two preclinical candidates & advanced research programs targeting oncology, bone disorders, & infectious diseases.